Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

Comorbid asthma, nonsmoking status, and the ethmoid/maxillary sinus ratio were significant predictors of eosinophilic CRSwNP.

Dupilumab was effective for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) at 52 weeks.

When a cat gets a stuffy nose, it’s easy to assume a kitty cold is the culprit…especially if they’re also sneezing and ...

Last year, Priyanka Chopra opened up about a cosmetic procedure she deeply regrets. During an interview on Howard Stern’s ...

Discover how asthma contributes to bronchiectasis development through sinusitis and inflammation. Learn about new findings ...

Nasal sinusitis, commonly called a sinus infection, is a condition characterised by inflammation or swelling of the tissue ...

Medically reviewed by Anju Goel, MD A deviated septum, or nasal septum deviation (NSD), is when the septum (the thin wall ...

This is not typically the first line of treatment but it may be recommended if other medications and treatments are not ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...